Rifampin-resistant mutants of Escherichia coli were isolated which had altered patterns of resistance or sensitivity to the inhibitory compounds 5-methyltryptophan and 5-methylanthranilate. The levels of tryptophan (trp) operon polypeptides in different rifampin-resistant mutants were elevated or reduced, in a manner consistent with their sensitivity to the two analogs. Complementation tests established that the mutations were in rpoB, the structural gene for the ,B subunit of ribonucleic acid polymerase. Introduction of these rpoB mutations into mutant strains which terminate transcription abnormally at the tip operon attenuator established that the rpoB mutations alter trp operon expression by increasing or decreasing transcription termination at the attenuator. The rpoB mutations affected transcription termination at the attenuator only in strains which were able to form what is thought to be a ribonucleic acid termination structure. These findings suggest that alteration of the f8 subunit of ribonucleic acid polymerase directly or indirectly affects ribonucleic acid polymerase's recognition of the transcription termination signal at the trp operon attenuator.
Rifampin-resistant mutants of Escherichia coli were isolated which had altered patterns of resistance or sensitivity to the inhibitory compounds 5-methyltryptophan and 5-methylanthranilate. The levels of tryptophan (trp) operon polypeptides in different rifampin-resistant mutants were elevated or reduced, in a manner consistent with their sensitivity to the two analogs. Complementation tests established that the mutations were in rpoB, the structural gene for the ,B subunit of ribonucleic acid polymerase. Introduction of these rpoB mutations into mutant strains which terminate transcription abnormally at the tip operon attenuator established that the rpoB mutations alter trp operon expression by increasing or decreasing transcription termination at the attenuator. The rpoB mutations affected transcription termination at the attenuator only in strains which were able to form what is thought to be a ribonucleic acid termination structure. These findings suggest that alteration of the f8 subunit of ribonucleic acid polymerase directly or indirectly affects ribonucleic acid polymerase's recognition of the transcription termination signal at the trp operon attenuator.
Transcription of the tryptophan (t7p) operon of Escherichia coli is regulated at a promoteroperator site and at a transcription termination site called the attenuator (26) . The attenuator is located in the transcribed region immediately preceding the structural genes of the operon (3, 12, 24) . When DNA restriction fragments containing the initial segment of the operon are transcribed in vitro, most RNA polymerase molecules terminate transcription at the attenuator and form a stable RNA-DNA-polymerase complex (8, 13 ; Winkler and Yanofsky, manuscript in preparation). Single base-pair mutations in the attenuator region appreciably reduce transcription tennination in vivo and in vitro (24, 31) , indicating that RNA polymerase must recognize some feature of the transcript, template, or transcript-template complex as the termination signal. Various lines of evidence suggest that a base-paired structure in the RNA transcript is at least one component of the transcription termination signal (13, 17, 30, 31) . Thus, mutations that disrupt base pairing in this structure, and, hence, its stability, reduce termination in vivo and in vitro (24, 31) . In addition, substitution of ITP for GTP as substrate in the in vitro reaction eliminates termination at the attenuator (13) . Presumably replacing G C base pairs in the transcript by the weaker I = C base pairs destabilizes the base-paired region, and this eliminates termination.
Studies with RNA polymerase mutants have shown that polymerase alterations can markedly affect the efficiency of transcription termination in vivo and in vitro (6, 10, 16, 28) . In particular, the studies of Neff and Chamberlin (16) 
MATERIALS AND METHODS
The bacterial strains employed in this study are described in Table 1 .
Selection of rifampin-resistant (Rif') strains.
The procedure of Leive (14) was followed with minor modifications. Cultures of strains CY15001 (trpR), CY15006 (thpR trpL29), and CY15007 (tipR trpL75) were grown in L broth (15) codon for the synthesis of the tip leader peptide; this mutation increases transcription termination at the attenuator in vivo (30, 31) . Mutation at position 75 of the leader region; this mutation increases transcription termination at the attenuator in vivo (30, 31) . Mutation at position 117 in the leader region; this mutation partially destabilizes a base-paired structure in the RNA transcript of the leader region and results in reduced termination at the attenuator in vivo and in vitro (24) .
A temperature-sensitive mutation affecting tRNA"TP that results
in reduced termination at the attenuator in vivo (7, 27 starting cultures were used to insure sampling of in-the latter three amino acids appeared to enhance the dependent events. distinction between sensitive and resistant colonies.
Detection of termination mutants. Rifampin-re-
The responses of the various strains on 5MT agar sistant mutants were patched onto master plates of L-and MAA agar at 30°C and 41°C are summarized in broth agar plus rifampin (100,ug/ml) and replicated to Table 2 . Generally, 5MT resistance was scored at 5MT agar (containing minimal agar, 0.2% glucose, 20 41°C, whereas MAA resistance was scored at 30°C. .&g of DL-5-methyltryptophan per ml, and 0.2% acid-Rifampin-resistant colonies that exhibited differences hydrolyzed casein) and MAA agar (containing minimal in resistance to 5MT or MAA were picked, purified, agar, 0.2% glucose, 100 Ag of 5-methylanthranilate per and grown for tip enzyme assays. The rpoB alleles of ml, 50 ug of L-cysteine per ml, 40 tg of L-leucine per mutants with altered enzyme levels were transduced ml, and 40 ug of L-methionine per ml). The addition of into their corresponding parental strains, and enzyme Straina CY15001 CY15002 CY15003 CY15004 CY15005 CY15006 CY15007 trpR trpL75 CY15008 trpR trpL117- 1   CY15009   N01602   CY15010  CY15011  CY15012  CY15013  CY15014  CY15015  CY15016  CY15017  CY15018  CY15019  CY15020  CY15021  CY15022  CY15023  CY15024  CY15025  CY15026  CY15027  CY15028  CY15029  CY15030  CY15031  CY15032  CY15033  CY15034  CY15035  CY15036 VOL. 145, 1981 on November 6, 2017 by guest http://jb.asm.org/ Downloaded from assays were performed on the tranaductants to be certain that each Rif' mutation was responsible for the trp enzyme level change.
Determination of t*p enzyme levels. Each culture was grown for at least three generations in minimal medium containing 0.2% glucose, 0.05% acid-hydrolyzed casein, and 50 pg of L-tryptophan per ml. Cells were harvested at a density of 6 x 108 to 7 x 108 cells per ml, washed with saline, suspended in 0.1 M Tris-HCl (pH 7.8), and disrupted by sonic oscillation. Cell debris was removed, and the supernatant was assayed for trp enzymes by previously described procedures (5, 23) . Strains with the trpT(Ts) allele (7, 27) were grown at 356C, as were all strains with which they were compared. All other strains were grown at 370C.
RESULTS
Selection of rifampin-resistant mutants with altered expression of the thp operon. E. coli mutant strains which have high levels of the five tip operon polypeptides will grow in the presence of 5-methyltryptophan but are inhibited by 5-methylanthranilate (30, 31) . We assume that such cells establish a higher internal concentration oftoxic 5-methyltryptophan when they synthesize it from 5-methylanthranilate than when they transport the 5-methyltryptophan from the culture medium. Thus, trpR mutants, mutants which lack a functional trp repressor, are normally resistant to 5-methyltryptophan and sensitive to 5-methylanthranilate.
However, strains which are trpR and contain the trpL29 or trpL75 mutation are inhibited by 5- methyltryptophan and resistant to inhibition by 5-methylanthranilate (30 Cultures of strains CY15001 (tp)), CY15006 (trpR trpL29), and CY15007 (tipR tipL75) were plated on rifampin agar, and the resistant colonies which spontaneously developed were picked and patched onto master plates. The master plates were then replica plated to agar containing 5-methyltryptophan or 5-methylanthranilate (Fig. 1) . Colonies phenotypically different from the plated strains were readily apparent. These colonies were picked and purified for further study.
tip enzyme levels in rifampin-resistant mutants and transductants. Strains CY15010 (trpR trpL29 rpoB2) and CY15013 (tipR trpL75 rpoB6) were obtained by selecting rifampin-resistant, 5-methyltryptophan-resistant colonies, as described above (evidence that the Riff mutations are in rpoB will be presented in the next section). The rpoB2 and rpoB6 alleles were transduced into a variety of strains which were then grown for tip enzyme level determinations. The rpoB2 and rpoB6 alleles, when present in strains with tipR and either thpL29 or trpL75, elevated tip operon expression about three-to fourfold (Table 3 ). This increase accounts for the phenotypic change in these strains of acquisition of resistance to 5-methyltryptophan. The rpoB2 and rpoB6 alleles have only a small effect on tip enzyme levels when introduced into the parental tipR strain, CY15001. They elevate enzyme levels only about 30% (see CY15014 and CY15015 in Table 3 ). That these rpoB alleles increase expression by reducing termination at the tip attenuator is shown by the data in Table   4 . Deletion of the attenuator, inactivation of the attenuator by mutation, and introduction of a t7pT(Ts) allele that relieves termination at the attenuator each prevents an observable effect of these rpoB alleles on tip operon expression. Rif relieve polarity-associated termination. To test this possibility, we introduced the rpoB2 and rpoB6 alleles into trpR strains that have the strongly polar trpC nonsense mutation, trpC315(Am). We then assayed the levels of the polypeptide products of trpE, trpD, trpB, and trpA. The ratios of trpB/trpE activities and trpA/trpD activities (data not shown) indicated that the two rpoB alleles tested had no significant effect on the translational polarity associated with the trpC315 mutation.
Mutations to rifampin resistance were also detected that had the opposite effect, namely, they decreased trp operon expression ( Table 5) . The rpoB7 and rpoB8 mutations detected in the CY15001 parental trpR strain decreased trp enzyme levels in the parent and when introduced into CY15002 (trpR AtrpE5), CY15003 (trpR A(tipED)24), CY15006 (trpR trpL29) and CY15007 (trpR trpL75), but not in CY15004 (trpR A(trpLD)102) or CY15005 (trpR A(trpLE)1417). These observations indicate that these Rif' alleles also affect termination at the trp operon attenuator. The rpoB7 and rpoB8 alleles also decreased expression in strains with the trpLll 7-1 mutation (CY15031, CY15032; Table 5), but did not depress and, in fact, slightly elevated tip enzyme levels in the CY15036 (trpT) strain.
Complementation analyses with rifampin-resistant mutants. Rifampin-resistant mutants are generally altered in rpoB, the structural gene for the ,B subunit of RNA polymerase (6, 10, 16, 28 (4, (18) (19) (20) . Rho factor is required for termination at some of these sites, whereas at others, termination occurs without this or any other accessory factor (18) (19) (20) . Transcription termination sites consist of GC-rich regions of DNA that are immediately Rif' MUTATIONS AND typ OPERON 1981 followed by AT-rich segments within which termination occurs (18, 20) . The GC-rich regions often exhibit dyad symmetry. It is thought that this symmetry reflects the stable base pairing of corewponding segments of the RNA transcript, and that such base-paired structures function as termination signals (2, 20, 21) . How the rho factor participates in those termination events in which it is involved is not known. Nor is it known how release of the transcript and template from RNA polymerase is accomplished. Release occurs spontaneously in vitro at some termination sites, whereas at others, the rho factor mediates dissociation of the termination complex (4, 9, (18) (19) (20) .
Mutant RNA polymerases have been described that are defective in termination in vivo and in vitro (6, 10, 16, 28) . rpoB mutations in particular appear to affect the efficiency of the termination event, implicating the fi subunit of RNA polymerase in recognition of the transcription termination signal (6, 10, 16, 28) . Since the ,B subunit is believed to contain the nucleoside triphosphate binding site, perhaps it also interacts with the 3' end of the growing or to-beterminated transcipt (22, 29) . The spatial relationships of template, transcript, and polymerase in the termination complex have yet to be elucidated.
Studies on transcription termination at the tip attenuator and its regulation have served as the basis for the development of a model that attempts to account for these events (12, 17, 30) . It is assumed that when RNA polymerase transcribes the initial segment of the tip operon, the transcript segment from nucleotides 110 to 130 forms a hydrogen-bonded structure (the termination structure) that is recognized by the transcribing polymerase as the transcription termination signal. The termination structure has been shown to form in vitro (13, 17) , and is thought to form in vivo in cells that have an adequate supply of tryptophan. In celLs that are starved of tryptophan, however, this structure presumably does not exist because a competing base-paired structure forms first and temporarily prevents the base pairing that generates the termination structure. We believe that the competing base-paired structure forms because the ribosome translating the initial segment of the transcript "stalls" over one of the adjacent tryptophan codons at nucleotides 54 to 59 in the transcript and that this allows formation of the competing structure (17, 31) . Within the framework of this model, we can account for the characteristics of the different types of tip operon mutations used in the present study (17, 31 Rif' mutations that lead to reduced transcription termination at the tip attenuator are readily detected in mutant strains CY15006 (trpR trpL29) and CY15007 (tipR trpL75), strains in which the in vivo termination frequency at the t*p attenuator is abnormally high. We believe that termination is frequent in these strains because in vivo, the termination structure forms more often than in the wild-type strain (31) . We interpret the Rifr termination relief mutations as alterations of the j9 subunit of RNA polymerase that reduce the efficiency of termination whenever RNA polymerase encounters a transcript termination structure. Consistent with this interpretation is the finding that these Rfr mutations had no effect on operon expression when introduced into attenuator deletion, attenuator point mutation, and trpT(Ts) strains, all of which are thought not to form the normal tanscript termination structure. These Rif' mutations had only a small effect when introduced into the parental trpR strain, CY15001, reducing transcription termination sufficiently to give only a 30% increase in expression. This finding is consistent with the interpretation that when the wild-type leader region is transcribed, the termination structure forms less often than in strains with the trpL29 and trpL75 mutations.
We have also detected Rif mutations that increase transcription termination at the trp attenuator. These mutations allow growth of trpR strains on 5-methylanthranilate. As expected, these mutations decreased expression in tip deletion attenuator-containing strains but did not do so in attenuator deletion strains or the thpR(Ts) strain (Table 5) . Surprisingly, they decreased expression in strains with the trpL29, trpL75, and trpL117-1 mutations (Table 5) . We surmise that this is the case because these Rifr polymerases terminate transcription more efficiently than the wild-type polymerase when they encounter the trpL29, trpL75, and trpL117-1 transcript termination structures. We cannot explain the 50% increase in operon expression in CY15036, the trpR trpT(Ts) rpoB7 strain. However, of the strains tested, only this one was extraordinarily slow-growing on either rich or minimal medium. This behavior may indicate that the particular combination of mutations in this strain has some adverse effect. 
